Billiontoone (NASDAQ:BLLN) SVP Sells 1,416 Shares of Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction that occurred on Thursday, September 24th. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00. Following the transaction, the senior vice president directly owned 22,219 shares of the company’s stock, valued at approximately $2,666,280. This trade represents a 5.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $106.61, for a total transaction of $150,959.76.
• On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64.
• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.

Billiontoone Price Performance

Shares of BLLN stock traded down $1.36 during mid-day trading on Monday, hitting $121.72. 343,637 shares of the stock were exchanged, compared to its average volume of 551,483. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $150.44. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The company has a market cap of $5.74 billion and a PE ratio of 173.89. The firm has a fifty day moving average of $108.73 and a 200 day moving average of $98.51.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Research analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently commented on BLLN. Wall Street Zen cut Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Canaccord Genuity Group initiated coverage on Billiontoone in a research report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price on the stock. Guggenheim assumed coverage on shares of Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 price target on the stock. JPMorgan Chase & Co. cut their price target on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a report on Thursday, August 6th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Billiontoone in a research report on Friday, September 18th. Seven analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $125.88.

Institutional Trading of Billiontoone

Large investors have recently made changes to their positions in the company. Sei Investments Co. acquired a new position in Billiontoone in the 1st quarter valued at $1,058,000. The Manufacturers Life Insurance Company lifted its holdings in Billiontoone by 151.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after purchasing an additional 18,389 shares in the last quarter. Wasatch Advisors LP boosted its stake in Billiontoone by 40.2% during the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares during the last quarter. Emerald Mutual Fund Advisers Trust grew its holdings in shares of Billiontoone by 11.9% during the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after buying an additional 14,072 shares in the last quarter. Finally, Perceptive Advisors LLC grew its holdings in shares of Billiontoone by 26.1% during the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after buying an additional 19,000 shares in the last quarter.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.